Q1 EARNINGS: Bard and bioMérieux up, while Intuitive sales sink
This article was originally published in Clinica
Robotic surgery specialist Intuitive Surgical’s rough patch continues: its first-quarter sales fell 24% to $464.7m, also short of Canaccord Genuity analyst Jason Mills’ prediction of $567m. He wrote: “We had predicted a bumpy ride for Intuitive entering 2014; this has turned into a steep descent highlighted by myriad challenges – many of which have plagued the company over the past 1.5+ years.”
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.